Who owns ImmunoGen?

Key details on ImmunoGen (Ticker: IMGN)

Who owns ImmunoGen?

Is IMGN a good stock to own? Find out who bought ImmunoGen, who sold ImmunoGen (IMGN) stock, and who holds a large position in ImmunoGen.

Fund Name Number of Shares Share Valuation As Of
ClearBridge Advisors 14.45M $129.34M March 31, 2015
PRIMECAP Management Company 12.87M $185.03M June 30, 2015
FMR 8.96M $128.84M June 30, 2015
First Trust Advisors 5.81M $61.55M Sept. 30, 2014
Vanguard 5.72M $82.31M June 30, 2015
STATE STREET CORPORATION 3.27M $47.02M June 30, 2015
BlackRock Fund Advisors 3.18M $45.67M June 30, 2015
Wellington Management Company 3.13M $46.68M March 31, 2014
BB Biotech AG 2.84M $25.43M March 31, 2015
BlackRock Institutional Trust Company, N.A. 2.29M $32.95M June 30, 2015
Sectoral Asset Management 2.27M $24.04M Sept. 30, 2014
OrbiMed Advisors 1.93M $28.14M Sept. 30, 2012
Artal Group S.A. 1.90M $20.12M Sept. 30, 2014

Who sold ImmunoGen?

Fund Name Date Sold Number of Shares Sold Share Valuation
Norges Bank Investment Management Dec. 31, 2013 2.37M $34.81M